Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
03/2003
03/20/2003CA2460269A1 Alphavirus replicon vector systems
03/20/2003CA2460117A1 Expression profiling in the intact human heart
03/20/2003CA2459769A1 Igf-1 as feline vaccine adjuvant, in particular against feline retroviruses
03/20/2003CA2459560A1 Methods of kidney transplantation utilizing developing nephric tissue
03/20/2003CA2459318A1 Nucleic acid and corresponding protein entitled steap-1 useful in treatment and detection of cancer
03/20/2003CA2459202A1 Adipose-derived stem cells and lattices
03/20/2003CA2458543A1 Compositions and methods for treatment of cancer
03/20/2003CA2457282A1 Method for expression of small antiviral rna molecules within a cell
03/20/2003CA2456310A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
03/20/2003CA2455990A1 Methods for diagnosing and treating diseases and conditions associated with protein kinase c.lambda.
03/20/2003CA2454992A1 Adenoviral vector and related system and methods of making and use
03/20/2003CA2451454A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
03/20/2003CA2451254A1 Novel proteins and nucleic acids encoding same
03/19/2003EP1293570A2 Application of aprataxin gene to diagnosis and treatment for early-onset spinocerebellar ataxia (EAOH)
03/19/2003EP1293565A2 Mammalian telomerase RNA component
03/19/2003EP1293563A1 Inhibition of apoptosis by the expression of antisense rna of caspase-3
03/19/2003EP1293559A1 Gas driven gene delivery instrument
03/19/2003EP1292695A2 Gene-regulating conjugates
03/19/2003EP1292694A2 A recombinant non-replicating virus expressing gm-csf and uses thereof to enhance immune responses
03/19/2003EP1292680A2 Agonist anti-trk-c monoclonal antibodies
03/19/2003EP1292676A1 Mutation associated with epilepsy
03/19/2003EP1292675A2 Method of diagnosing, monitoring, staging, imaging and treating colon cancer
03/19/2003EP1292674A2 Nucleotide sequences involved in increasing or decreasing mammalian ovulation rate
03/19/2003EP1292671A1 Method for obtaining characterised muscle-derived cell populations and uses
03/19/2003EP1292668A2 Gene disruption methodologies in fungi for drug target discovery
03/19/2003EP1292619A2 B7-related nucleic acids and polypeptides and their uses for immunomodulation
03/19/2003EP1292616A2 Nucleic acids encoding a regulator of g protein signaling, rgs18, and uses thereof
03/19/2003EP1292606A2 Positively-charged peptide nucleic acid analogs with improved properties
03/19/2003EP1292605A2 Antisense modulation of inhibitor of dna binding-1 expression
03/19/2003EP1292340A1 Transfection system
03/19/2003EP1292337A2 Multivalent platform molecules comprising high molecular weight polyethylene oxide
03/19/2003EP1292331A2 Immunostimulatory rna/dna hybrid molecules
03/19/2003EP1292289A2 Compositions and methods for treating neoplastic disease using chemotherapy and radiation sensitizers
03/19/2003EP1292285A1 Delivery systems for bioactive agents
03/19/2003EP1292284A2 Encapsulation of polynucleotides and drugs into targeted liposomes
03/19/2003EP1292186A1 Animal and cell models for type ii diabetes and their use
03/19/2003EP0996337A4 A process of delivering a polynucleotide via the vascular system
03/19/2003EP0964697B1 Therapeutic applications of antigens or epitopes associated with impaired cellular peptide processing, e.g. expressed on rma-s cells transfected with a b7-1 gene
03/19/2003EP0910409A4 Recombinant constructs encoding t cell receptors specific for human hla-restricted tumor antigens
03/19/2003EP0876482B1 Il-13 receptor polypeptide
03/19/2003EP0745094B1 Superagonists and antagonists of human il-6, and method for their selection
03/19/2003EP0670904B1 Vector for the expression of therapy-relevant genes
03/19/2003CN1404400A Use of IL-18 inhibitors
03/19/2003CN1404398A Improved DNA vaccines for production-type animals
03/19/2003CN1403159A Application of matrix metalloprotease tissue inhibitor in preparing medicine for preventing and treating arthritis
03/19/2003CN1103370C Recombination human immunodeficiency virus producing cell
03/18/2003US6534643 Isolated nucleic acid of given sequence; useful for homology-dependent pairing of three DNA strands; use in cloning and gene mapping
03/18/2003US6534642 Isolated nucleic acid of given sequence encoding a protein; dysfunction of the human protein implicated in hyper/hypocalcemia, bone disorders, leukemia and cancer
03/18/2003US6534641 Genes which are differentially expressed in cardiovascular disease states, relative to their expression in normal, or non-cardiovascular disease states, and/or in response to manipulations relevant to cardiovascular disease.
03/18/2003US6534640 Methods and compositions to alter the cell surface expression of phosphatidylserine and other clot-promoting plasma membrane phospholipids
03/18/2003US6534639 Guanidinium functionalized oligonucleotides and method/synthesis
03/18/2003US6534630 Connective tissue growth factor-2
03/18/2003US6534538 A non-murine heart valve cell containing an exogenous nucleic acid that encodes a polypeptide having nitric oxide synthase activity; slows heart valve degeneration, thrombosis, and calcification, treats carcinoid heart disease
03/18/2003US6534485 Novel human protein called Bone Marrow-Specific Protein (BMSP), and isolated polynucleotides encoding this protein. Also provided are vectors, host cells, antibodies, and recombinant methods for producing this human protein.
03/18/2003US6534483 Protected one-vial formulation for nucleic acid molecules, methods of making the same by in-line mixing, and related products and methods
03/18/2003US6534476 Smad6 and uses thereof
03/18/2003US6534310 Suppression of proteolytic activity by dysfunctional protease formation
03/18/2003US6534275 Isolated polypeptide having specified amino acid sequence or immunogenic fragment thereof
03/18/2003US6534268 Isolated nucleic acid corresponding to specified nucleotide sequence that encodes human bone morphogenetic protein-7 promoter region
03/18/2003US6534261 Regulation of endogenous gene expression in cells using zinc finger proteins
03/18/2003US6534056 Therapeutic and diagnostic uses of protein tyrosine phosphatase TC-PTP
03/18/2003US6534055 Methods for selectively stimulating proliferation of T cells
03/18/2003US6534051 Cell type specific gene transfer using retroviral vectors containing antibody-envelope fusion proteins and wild-type envelope fusion proteins
03/18/2003CA2121370C Specific tolerance in transplantation
03/17/2003WO2002022833A1 Fusion protein from antibody cytokine-cytokine inhibitor (selectokine) for use as target-specific prodrug
03/17/2003CA2422759A1 Fusion protein from antibody cytokine-cytokine inhibitor (selectokine) for use as target-specific prodrug
03/14/2003WO2003025166A1 Therapeutic vaccination method, mutated peptides of hiv reverse transcriptase and their use for vaccination and diagnostic purposes
03/14/2003CA2460377A1 Therapeutic vaccination method, mutated peptides of hiv reverse transcriptase and their use for vaccination and diagnostic purposes
03/13/2003WO2004043335A2 Methods of treating infection by drug resistant bacteria
03/13/2003WO2003021227A2 Methods and compositions useful for diagnosis, staging, and treatment of cancers and tumors
03/13/2003WO2003020954A2 205p1b5 in treatment and detection of cancer
03/13/2003WO2003020931A2 Sirna knockout assay method and constructs
03/13/2003WO2003020901A2 Compositions and methods relating to prostate specific genes and proteins
03/13/2003WO2003020894A2 Insulin related transcription factor and uses thereof
03/13/2003WO2003020893A2 New adenovirus type 7 vectors
03/13/2003WO2003020876A2 Polynucleotides encoding antigenic hiv type b polypeptides, polypeptides and uses thereof
03/13/2003WO2003020763A2 Soluble t cell receptor
03/13/2003WO2003020759A2 A caspase- 8 binding protein, its preparation and use
03/13/2003WO2003020753A1 Peptidic compounds selectively binding to p-selectin
03/13/2003WO2003020739A2 Novel lna compositions and uses thereof
03/13/2003WO2003020309A2 Compound
03/13/2003WO2003020287A2 Methods for the treatment of chronic pain anc compositions therefor
03/13/2003WO2003020223A2 A cancer treatment system
03/13/2003WO2003020205A2 Non-mammalian gnrh analogs and uses thereof in regulation of fertility and pregnancy
03/13/2003WO2003020172A1 An implantable and sealable system for unidirectional delivery of therapeutic agents to targeted tissues
03/13/2003WO2003000174A3 Compositions and methods for intracellular delivery
03/13/2003WO2002095006A3 Muscle-specific expression vectors
03/13/2003WO2002083840A3 Compositions and methods for transepithelial transport of membrane-bounded vesicles and virions
03/13/2003WO2002078606A3 Thrombospondin-2 and uses thereof
03/13/2003WO2002077217A3 Human dual specificity protein phosphatase 7-like protein
03/13/2003WO2002074158A3 Two-phase processing of thermosensitive polymers for use as biomaterials
03/13/2003WO2002068654A3 Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus
03/13/2003WO2002068629A3 Dna constructs for cytoplasmic and mithochondrial expression and methods of making and using same
03/13/2003WO2002067996A3 Beta-endorphin/crf gene therapy for locally combating pain
03/13/2003WO2002064741A3 Compositions and methods relating to breast specific genes and proteins
03/13/2003WO2002062820A3 Haplotypes of the cyp27b1 gene
03/13/2003WO2002056668A3 Methods to control the host range of retroviral vectors
03/13/2003WO2002047717A3 Targeted enzyme prodrug therapy
03/13/2003WO2002046412A3 Regulation of angiogenesis with zinc finger proteins
03/13/2003WO2002044381A3 Human vno receptor (r1)
1 ... 532 533 534 535 536 537 538 539 540 541 542 543 544 545 546 547 548 549 550 551 552 ... 870